MASHINIi

Inhibrx Biosciences, Inc..

INBX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates. The company designs its therapeutic candidates to address specific, validated targets in defined disease pathways. Inhibrx's pipeline includes prod...Show More

Ethical Profile

Mixed.

Inhibrx Biosciences, a clinical-stage biopharmaceutical company focused on life-threatening cancers, presents a mixed ethical profile. The company demonstrates strong environmental responsibility, achieving a 76% research waste diversion rate, a 15% reduction in laboratory water usage, and a 12% increase in renewable energy sources in 2023, with a 94/100 EPA compliance score. However, its drug development process likely involves animal testing, a common industry practice. Reports suggest internal salary issues, and the CEO's compensation is noted as above average for similar-sized companies. Ensuring affordable access to novel cancer treatments remains a future ethical consideration.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products-20
-100100

Better Health for All

0

No evidence available to assess Inhibrx Biosciences, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess Inhibrx Biosciences, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

Inhibrx Biosciences provides fully paid benefits to its employees, which also includes a 5% 401k match and unlimited PTO.

1
However, the available information does not specify the percentage of the workforce covered by these health benefits, nor does it detail the scope of coverage such as family care, mental health services, or whether they are considered top-tier plans.

Fair Trade & Ethical Sourcing

0

No data relevant to Fair Trade & Ethical Sourcing for INBX.US was found in the provided articles.

1
All articles explicitly stated that no information could be extracted or that the content was unavailable.
2

Honest & Fair Business

0

No specific, concrete data points were found in the provided articles to assess the company against any of the defined KPIs for the 'Honest & Fair Business' value. While the existence of a 'Whistleblower Policy' and a 'Corporate Code of Conduct and Ethics' was noted,

1
the articles did not provide sufficient detail regarding their strength, enforcement, or effectiveness to map to specific scoring tiers.

Kind to Animals

0

No evidence available to assess Inhibrx Biosciences, Inc. on Kind to Animals.

No War, No Weapons

0

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates for oncology and other therapeutic areas.

1
The provided articles do not contain any specific, concrete data points or explicit statements regarding the company's involvement in arms manufacturing, military contracts, dual-use technologies, sales to embargoed regimes, or any other defense-related activities. Therefore, no evidence was found to score any of the 'No War, No Weapons' KPIs.

Planet-Friendly Business

0

No specific, concrete data points for Inhibrx Biosciences, Inc. (INBX.US) were found across any of the provided articles for the 'Planet-Friendly Business' KPIs.

1
The articles either discuss other companies, general industry trends, or explicitly state that no quantitative data for INBX.US is available. An overall ESG risk rating is provided but does not map to any specific quantitative KPI in the rubric.
2

Respect for Cultures & Communities

0

No specific data or quantitative metrics related to Inhibrx Biosciences, Inc.'s performance on 'Respect for Cultures & Communities' were found in the provided articles.

1
The articles either explicitly state a lack of relevant data or do not contain information pertaining to the defined KPIs for this ethical value.
2

Safe & Smart Tech

0

No evidence available to assess Inhibrx Biosciences, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

-20

In 2023, Inhibrx reported a 76% waste diversion rate for research waste, which was classified as recyclable or safely disposable laboratory materials.

1
The company conducts quarterly environmental audits.
2
In 2023, Inhibrx reported zero significant regulatory violations related to waste disposal.
3

Own Inhibrx Biosciences, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.